Publications by authors named "Shenhao Xu"

Claim this Profile
C
Constructing a PANoptosis-based prognostic signature to evaluate the immune landscape and therapeutic response in clear cell renal cell carcinoma.
Yu Dong, Zitong Yang, Zhinan Xia, Jiahao Liao, Zhiming Cui, Shenhao Xu

J Zhejiang Univ Sci B· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hederagenin exerts anti-tumor effects in pancreatic cancer by impairing DRP1 mediated-mitophagy via VDAC1-HK2-PINK1/PARKIN pathway.
Fang Su, Jianhua Yu, Shenhao Xu, Huanjun Tong, Jiandong Li

Toxicol Appl Pharmacol· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Serological and molecular survey of hepatitis E virus in pets in shaanxi, China.
Yiyang Chen, Huanqing Lin, Shenhao Xu, Longzhi Nie, Yujia Tang

BMC Vet Res· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of novel synthetic peptides of avian hepatitis E virus ORF2 as vaccine candidate in chickens.
Yiyang Chen, Yujia Tang, Shiyu Zhang, Yinuo Tian, Shenhao Xu

Virus Res· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Computed Tomography Measures of Perinephric Adipose Tissue and C-Reactive Protein-to-Albumin Ratio are Associated with Common Prognostic Models for Nonmetastatic Clear Cell Renal Cell Carcinoma Patients.
Bing Liu, Zhiming Cui, Shenhao Xu, Cheng Zhang

Arch Esp Urol· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pathogenicity of two different genotypes avian hepatitis E strains in laying hens and silkie fowl.
Yiyang Chen, Shenhao Xu, Yujia Tang, Chengwei Zhang, Longzhi Nie

Virology· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Aerobic glycolysis of vascular endothelial cells: a novel perspective in cancer therapy.
Shenhao Xu, Jiahao Liao, Bing Liu, Cheng Zhang, Xin Xu

Mol Biol Rep· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Integration analysis identifies MYBL1 as a novel immunotherapy biomarker affecting the immune microenvironment in clear cell renal cell carcinoma: Evidence based on machine learning and experiments.
Tengda Wang, Wengang Jian, Wei Xue, Yuyang Meng, Zhinan Xia, Shenhao Xu

Front Immunol· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis